EOS imaging Announces the Installation of the 50th EOS® System in France

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

The EOS® solution is now available at the Villeneuve d’Ascq Private Hospital site, a member of the Ramsay Générale de Santé group

EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the 50th installation of an EOS® system in France at the Imanord medical imaging center in the Hôpital Privé Villeneuve d’Ascq, a member of the Ramsay Générale de Santé network, which is the largest private hospital group in France.

This new installation is the fifth in the Hauts-de-France region, making it the fourth in numbers of EOS platforms following the Ile-de-France, Auvergne-Rhône Alpes and Provence-Alpes Côte d’Azur regions. 27% of French cities with more than 50,000 people are now equipped with at least one EOS system, with strong opportunities to further expand patient access in certain regions, including the suburban Paris area.

The EOS system will complement Imanord’s medical imaging platform which has numerous other advanced modalities, including MRI and PETscan, that enable the hospital to provide the best care for their patients. The EOS system will help develop the orthopedic care and spine programs at the hospital and will provide patients with access to 3D full body, low-dose imaging in a functional position.

Doctor Patrick Chastanet, Radiologist at Villeneuve d’Ascq Private Hospital, commented, “The installation of EOS at the Villeneuve d’Ascq Private Hospital will allow our patients to easily access this low dose technology in the Lille region of 1.2 million people who are currently being served by only one EOS at the Regional University Hospital of Lille. We are very happy to offer this innovative technology to our patients.”

Marie Meynadier, CEO of EOS imaging, added, “We are pleased that Villeneuve d’Ascq Private Hospital will be the 50thfacility in France to offer the EOS solution. Our technology is becoming a standard of care, and it is our goal to increase access for a greater number of patients in France and abroad.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles